Perfil de la empresa para EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT Acción
Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.
Datos de la empresa
NombreEUCRATES BIOMEDICAL ACQUISITION CORP - UNIT
EmpresaEucrates Biomedical Acquisition Corp.
SímboloEUCRU
Mercado principal
NASDAQ
ISINVGG3141W1142
Tipo de valorAcción
SectorFinancial Services
IndustriaShell Companies
CEOParag Phoolchand Saxena MBA, MS
Capitalización de mercado47 Mio
PaísEstados Unidos de América
MonedaUSD
Empleados-
Dirección250 West 55th Street, 10019 New York City
Fecha de OPV2020-10-06
Símbolos de cotización
Nombre
Símbolo
NASDAQ
EUCRU
Otras acciones
Los inversores que tienen EUCRATES BIOMEDICAL ACQUISITION CORP - UNIT también tienen las siguientes acciones en su cartera: